Bond.az White LogoBond.az Black Logo

GE Aerospace Defense Outlook Boosts Stock Rating

RBC Capital praises GE Aerospace's defense outlook, reiterating Outperform rating. Read about strong earnings and new contracts.

Benjamin Moore
ByBenjamin Moore- Senior Editor
|
0

Bond.az - RBC Capital reiterated an Outperform rating on GE Aerospace (NYSE:GE) with a $355.00 price target, following the company's Defense & Propulsion Technologies Showcase.

GE Aerospace provided a positive outlook for revenues and margins in its DPT segment, citing services, international mix, cost actions, and pricing as drivers.

The defense business is experiencing strong tailwinds, bookings strength, and market positioning that support growth above GE's prior medium-term guidance. RBC Capital noted the segment's performance exceeds expectations.

RBC Capital stated the defense business remains under-appreciated by investors and could be a source of upside for the company.

Market sentiment on GE Aerospace continues to focus on the Commercial Engines & Services outlook. RBC Capital maintained its Outperform rating and $355 price target.

In other recent news, GE Aerospace reported strong Q1 earnings: non-GAAP EPS of $1.86 beat consensus of $1.60, and adjusted revenue of $11.61 billion topped expectations of $10.69 billion. Bernstein SocGen Group reiterated an Outperform rating and $405 target. Additionally, GE Aerospace secured a U.S. Air Force contract for preliminary design review of its GE426 engine.

Meanwhile, UBS lowered its price target to $350 from $357 due to geopolitical concerns, but maintained a Buy rating. Morgan Stanley adjusted its target to $400 from $425, keeping an Overweight rating. GE Aerospace's CEO is also set to join a U.S. delegation to China.

This article was generated with AI support and reviewed by an editor. For more information see our T&C.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
GE Aerospace Defense Outlook Boosts Stock Rating | Bond.az